Skip to main content
OpenTrials

Clinical trial condition

Systemic Mastocytosis With an Associated Hematologic Neoplasm

Explore clinical trials studying Systemic Mastocytosis With an Associated Hematologic Neoplasm. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Systemic Mastocytosis With an Associated Hematologic Neoplasm trial results

Recruiting

Avapritinib With Decitabine in Patients With SM-AHN

NCT06327685

Conditions
Systemic Mastocytosis With an Associated Hematologic Neoplasm
Locations
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis

NCT03580655

Conditions
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Hematologic Diseases, +15 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 32 locations
View Trial Details

Related conditions